Lakeland Industries, Inc. (NASDAQ:LAKE) Receives Average Rating of “Hold” from Brokerages

Lakeland Industries, Inc. (NASDAQ:LAKE) has been assigned a consensus rating of “Hold” from the five ratings firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $16.00.

LAKE has been the topic of several research analyst reports. Lake Street Capital lowered their target price on Lakeland Industries from $16.00 to $13.00 and set a “buy” rating on the stock in a research note on Friday, April 17th. Maxim Group set a $16.00 target price on shares of Lakeland Industries in a research note on Monday, April 20th. DA Davidson raised their price objective on shares of Lakeland Industries from $14.00 to $18.00 and gave the stock a “buy” rating in a report on Thursday, June 11th. Wall Street Zen upgraded shares of Lakeland Industries from a “sell” rating to a “hold” rating in a research note on Sunday, July 12th. Finally, Weiss Ratings upgraded shares of Lakeland Industries from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, June 29th.

Hedge Funds Weigh In On Lakeland Industries

Several hedge funds have recently added to or reduced their stakes in the company. Private Capital Management LLC raised its holdings in Lakeland Industries by 2.8% during the 4th quarter. Private Capital Management LLC now owns 1,202,433 shares of the medical instruments supplier’s stock worth $10,630,000 after purchasing an additional 32,945 shares during the last quarter. Pacific Ridge Capital Partners LLC boosted its stake in Lakeland Industries by 62.3% in the fourth quarter. Pacific Ridge Capital Partners LLC now owns 772,015 shares of the medical instruments supplier’s stock valued at $6,825,000 after acquiring an additional 296,222 shares during the last quarter. Vanguard Group Inc. boosted its holdings in Lakeland Industries by 2.3% during the third quarter. Vanguard Group Inc. now owns 486,524 shares of the medical instruments supplier’s stock worth $7,201,000 after buying an additional 10,764 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Lakeland Industries by 115.9% in the 2nd quarter. Geode Capital Management LLC now owns 217,786 shares of the medical instruments supplier’s stock valued at $2,964,000 after acquiring an additional 116,901 shares during the last quarter. Finally, Expect Equity LLC raised its position in shares of Lakeland Industries by 6.9% in the 4th quarter. Expect Equity LLC now owns 166,061 shares of the medical instruments supplier’s stock valued at $1,468,000 after acquiring an additional 10,705 shares during the period. Institutional investors own 71.69% of the company’s stock.

Lakeland Industries Price Performance

Shares of NASDAQ:LAKE opened at $11.88 on Thursday. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.34 and a current ratio of 3.09. Lakeland Industries has a one year low of $7.15 and a one year high of $18.00. The company has a market capitalization of $117.24 million, a PE ratio of -5.58 and a beta of 1.45. The stock has a fifty day moving average of $10.84 and a 200-day moving average of $9.89.

Lakeland Industries (NASDAQ:LAKE) last issued its quarterly earnings results on Tuesday, June 9th. The medical instruments supplier reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.18. Lakeland Industries had a negative return on equity of 6.64% and a negative net margin of 10.87%.The firm had revenue of $47.42 million for the quarter, compared to analysts’ expectations of $47.36 million. As a group, equities analysts anticipate that Lakeland Industries will post -0.28 EPS for the current fiscal year.

About Lakeland Industries

Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.

The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.